Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:07 AM
Ignite Modification Date:
2025-12-25 @ 3:07 AM
NCT ID:
NCT04512833
Eligibility Criteria:
Inclusion Criteria:
* Primary HCC diagnosed by a surgeon and/or radiologist and oncologist according to the international guidelines for the management of HCC or by pathology
* Unfeasible or refusing to undergo other treatments;
* Residual normal liver volume ≥700 cc;
* With decompensated cirrhosis (Child-Pugh B or C classification);
* Without portal vein tumor thrombus;
* Eastern Cooperative Oncology Group (ECOG) score 0-1;
* Distances between tumor and normal organs (esophagus, stomach, duodenum, bowel) are more than 5 mm；
* Rejecting other therapies such as resection, liver transplantation, etc.
* Platelet count≥50 × 109/L, white blood count≥1.5 × 109/L;
* Patients infected with hepatitis B virus who are treated with adefovir or entecavir; patients infected with hepatitis C virus whose HCV DNA are negative.
Exclusion Criteria:
* With Tumor thrombus；
* With extrahepatic metastasis;
* With lymph node involvement.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT04512833
Study Brief:
Protocol Section:
NCT04512833